Today: 14 April 2026
RELX PLC stock slips in early London trade as buyback ticks on and Feb. 12 results loom
14 January 2026
1 min read

RELX PLC stock slips in early London trade as buyback ticks on and Feb. 12 results loom

London, January 14, 2026, 09:20 GMT — Regular session

  • RELX shares dipped 0.1% in early Wednesday trading, marking their third consecutive session of losses
  • Company announced a new round of share repurchases as part of its ongoing buyback programme
  • The next key date for investors: RELX’s annual results, coming Feb. 12

RELX PLC shares slipped 0.1% to roughly 3,120 pence in early London trading Wednesday, following two consecutive sessions of declines.

The modest shift happens as investors focus beyond the daily fluctuations, eyeing RELX’s full-year results set for Feb. 12. They’ll be watching closely for updates on growth in its data and analytics segments, along with how much cash the company plans to return to shareholders.

For now, the buyback is making its presence felt. When a company repurchases its own shares, it reduces the number of shares outstanding, which can boost earnings per share, even though the core business remains unchanged.

RELX revealed on Tuesday that it purchased 298,920 shares on the London Stock Exchange via UBS, at a volume-weighted average price near 3,153 pence. The company confirmed these shares will be held as treasury stock.

That’s significant—it ensures a consistent, price-insensitive buyer stays active, even as the stock drifts. Since Jan. 2, RELX has snapped up 2.48 million shares, according to the same filing.

Analysts are zeroing in as well. Citigroup kicked off coverage of RELX this week, assigning a neutral rating and setting a price target at 3,178 pence, MarketBeat reported.

The tape shows the stock trapped in a tight range for now. Traders are tracking if legal and risk clients continue shelling out for new tools, as generative AI accelerates product cycles throughout the information-services space.

On Tuesday, LexisNexis Risk Solutions, a unit of RELX, highlighted changing consumer habits in a U.S. vehicle loyalty study. Executive Dave Nemtuda described loyalty as a “critical competitive metric.” The unit’s data products serve insurers, automakers, and others. PR Newswire

Yet the risk is clear: if February’s results reveal slowing subscription growth, softer pricing, or clients tightening their belts, any boost from the buyback could quickly vanish—and the valuation debate would resurface.

The next checkpoint arrives on Feb. 12. Investors are also keeping an eye on daily buyback updates leading up to that date, looking for any hints the company might adjust its pace.

Stock Market Today

  • BSE and NSE Close on Ambedkar Jayanti; Market Update After US-Iran Talks Fail
    April 13, 2026, 9:58 PM EDT. The Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) are closed April 14 for Dr. Baba Saheb Ambedkar Jayanti. Equities, derivatives segments shut; commodity derivatives open only in evening. Markets paused after a sharp previous rebound as US-Iran peace talks collapsed. Sensex fell 702.68 points (-0.91%) and Nifty dropped 207.95 points (-0.86%) on April 13. Most sectors declined except power, defense, and telecom. Broader indices outperformed benchmarks, with midcap and smallcap down 0.5%. Analysts noted a potential bullish counterattack pattern despite recent drops, with Nifty support at 23,500 and resistance near 24,100. The rupee weakened 65 paise to 93.38 per dollar amid rising crude prices following US actions in the Strait of Hormuz.

Latest article

Marvell Stock Hits Record High After Nvidia’s $2 Billion Move and Amazon AI Chip Push

Marvell Stock Hits Record High After Nvidia’s $2 Billion Move and Amazon AI Chip Push

13 April 2026
Marvell Technology shares rose 2.1% to $131.22 Monday, hitting a record after Nvidia’s $2 billion investment and renewed optimism over Amazon’s AI chip business. The stock earlier touched $135.18. Barclays upgraded Marvell and raised its price target to $150, citing surging demand for optical products in AI data centers. Nvidia and Marvell plan to link custom chips for Nvidia’s NVLink Fusion platform.
Intel Stock Rally Extends as $100 Billion April Run Draws Fresh Wall Street Bets

Intel Stock Rally Extends as $100 Billion April Run Draws Fresh Wall Street Bets

13 April 2026
Intel shares climbed $2.09 to $64.47 by late morning Monday, extending a rally that has added over $100 billion in value across eight sessions. The surge follows a raised price target, new deals with Google and Elon Musk’s Terafab, and Intel’s $14.2 billion buyback of Apollo’s Fab 34 stake. The stock is up 69% in 2026 after an 84% gain last year. Intel reports first-quarter results April 23.
Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

13 April 2026
Nebius Group shares climbed 7.4% to $155.74 by midday Monday after Bank of America raised its price target to $175, despite Freedom Capital Markets downgrading the stock to Hold. The Amsterdam-based AI infrastructure firm recently secured a five-year deal with Meta worth up to $27 billion and holds over $40 billion in supply contracts with Microsoft and Meta. Nebius also closed $4.34 billion in convertible debt and sold $2 billion in warrants to Nvidia.
Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

13 April 2026
Salesforce faced renewed attention after reports of stake reductions by Choreo LLC and Sumitomo Mitsui Trust Group, based on SEC filings from January that reflected year-end positions. Choreo held 27,733 shares and Sumitomo Mitsui 2,478,864 shares as of December 31. The reported cuts amounted to about 35% and 8.6%, respectively. Salesforce shares rose 3.4% Monday, while broader software stocks remain down for the year.
GSK stock ticks up after Summit cancer-trial tie-up — what investors watch next
Previous Story

GSK stock ticks up after Summit cancer-trial tie-up — what investors watch next

Smith & Nephew stock drops in London as investors size up $450m Integrity Orthopaedics deal
Next Story

Smith & Nephew stock drops in London as investors size up $450m Integrity Orthopaedics deal

Go toTop